Adv. Shirin Herzog, a partner in our firm, was interviewed by Times of Israel as part of an article on […]
Adv. Shirin Herzog, a partner in our firm, represented American chocolate giant Mondelez (Toblerone, Milka) in its first investment in […]
Adv. Shirin Herzog, partner in our Corporate and Technology Department, was interviewed by Maariv on Track 43 of the Israel […]
An article by Adv. Shirin Herzog, partner in our Corporate and Technology Department, in an interview with Maariv on the […]
An article by Adv. Shirin Herzog, partner in our Corporate and Technology Department, on the impact of the coronavirus on […]
An article by Adv. Shirin Herzog, partner in our Corporate and Technology Department, on the future of start-up in Israel.
An article by Adv. Shirin Herzog, partner in our Corporate and Technology Department, on exposure of directors under the new […]
An article on the Bezeq shareholder meeting, featuring Adv. Shirin Herzog, partner in our Corporate and Technology Department.
An op-ed by Adv. Shirin Herzog, partner in our Corporate and Technology Department, on the Bezeq shareholder meeting.
An op-ed by Adv. Shirin Herzog, partner in our Corporate and Technology Department, on activist shareholders and board of directors’ […]
Adv. Shirin Herzog, partner in our Corporate and Technology Department, in an interview on the opportunities presented by the Concentration […]
Adv. Shirin Herzog, partner in our Corporate and Technology Department, in an interview on the Bezeq affair and corporate governance […]
Adv. Shirin Herzog, partner in our Corporate and Technology Department, in an interview on the braod implications for directors in […]
Adv. Shirin Herzog, partner in our Corporate and Technology Department, in an interview on the applicability of the Concentration Law […]
Adv. Shirin Herzog, partner in our Corporate and Technology Department, in an interview on Teva’s situation.
Adv. Shirin Herzog, partner in our Corporate and Technology Department, in an interview on the track for competing Intel’s purchase […]
Adv. Shirin Herzog, partner in our Corporate and Technology Department, in an interview on the extension of Intel’s purchase offer […]
An article by Adv. Shirin Herzog, partner in our Corporate and Technology Department, on Intel’s purchase offer of Mobileye shares.
An article by Adv. Shirin Herzog, partner in our Corporate and Technology Department, analyzing the conditions for the completion of […]
An article by Adv. Shirin Herzog, partner in our Corporate and Technology Department, analyzing the requirements for establishing a Board […]
An article by Adv. Shirin Herzog, partner in our Corporate and Technology Department, analyzing the Orix-Ormat transaction.
An article by Adv. Shirin Herzog, partner in our Corporate and Technology Department, on the Intel-Mobileye transaction.
Adv. Shirin Herzog, partner in our Corporate and Technology Department, in an interview on the ability to acquire Teva or […]
An op-ed by Adv. Doron Segal, partner in the Corporate and Capital Markets Department at Goldfarb Seligman, and Adv. Shirin […]
